A survey of about 18,000 residents training in internal medicine found that nearly three-fourths were unaware of the costs of the treatment that they prescribe for patients or the tests that they order.
A survey of about 18,000 residents training in internal medicine in the United States found that nearly three-fourths were unaware of the costs of the treatment that they prescribe for patients or the tests that they order.
The study was designed by the American College of Physicians and the Alliance for Academic Internal Medicine was designed to understand the knowledge of, attitude toward, and self-reported practice of High Value Care that balances the cost of care with benefits and harms among internal medicine residents.
A co-author on the study, which was published in the Academic Medicine: The Journal of the Association of American Medical Colleges, said she was surprised with the small number of residents who were aware of the costs of treatments and diagnostic tests and incoporated them into their clinical decisions.
These results have prompted the American College of Physicians to design a new curriculum that would train physicians to include costs and patient treatment goals in their clinical decisions.
Read more on MedpageToday.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More